Titan Medical Inc. completes C$12.8 million public offering

Date Closed: 2/19/2014

Value: C$12.8 million

On February 19, 2014, Titan Medical Inc. completed a public offering of 9,142,500 units. The Units were issued by Titan at a price of $1.40 per Unit for aggregate gross proceeds of $12,799,500 pursuant to an agency agreement dated February 10, 2014 with Dundee Securities Ltd., acting as agent. The Units were qualified for sale by a prospectus supplement dated February 10, 2014 to Titan’s short form base shelf prospectus dated October 15, 2012. Each Unit consists of one common share of Titan and one common share purchase warrant. Each whole Warrant entitles the holder thereof to acquire one Common Share at a price of $2.00 prior to the expiry time of 5:00 p.m. (Toronto time) on February 19, 2017. 

The net proceeds of the offering will be used by Titan for ongoing development and commercialization of robotic surgery technologies and general working capital requirements.

Titan was represented by BLG with a team consisting of Manoj Pundit, Habeeb Syed and Mark Lau (corporate and securities) and Natasha Miklaucic (tax).